Please use this identifier to cite or link to this item: http://repositorio.ufla.br/jspui/handle/1/57555
Full metadata record
DC FieldValueLanguage
dc.creatorCabral, Rosa Maria-
dc.creatorFerraz, Maíra S.-
dc.creatorRizzo, Márcia dos S.-
dc.creatorSousa, Francisco das Chagas A.-
dc.creatorRodrigues, Nirnheila M.-
dc.creatorIbiapina, Pollyanna B.-
dc.creatorAmbrósio, Carlos E.-
dc.creatorCarvalho, Maria Acelina M. de-
dc.date.accessioned2020-12-16T17:57:40Z-
dc.date.accessioned2023-06-27T19:38:29Z-
dc.date.available2020-12-16T17:57:40Z-
dc.date.available2023-06-27T19:38:29Z-
dc.date.issued2012-05-
dc.identifier.citationCABRAL, R. M. et al. Kidney injury and cell therapy: preclinical study. Microscopy Research and Technique, new York, v. 75, n. 5, p. 566-570, May 2012.pt_BR
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/abs/10.1002/jemt.21092pt_BR
dc.identifier.urihttp://repositorio.ufla.br/jspui/handle/1/57555-
dc.description.abstractThe aim of this study is to show histological and immunofluorescence analysis of renal parenchyma of agoutis affected by gentamicin‐induced renal disease after the infusion of bone marrow mononuclear cells (BMMC) stained with Hoechst®. Nine agouti's males were divided into three groups: Test group (TG): renal disease by gentamicin induced (n = 3), cell therapy group (CTG): renal disease by gentamicin induced and BMMC infusion (n = 3), and control group (CG): nonrenal disease and BMMC infusion (n = 3). TG and CTG were submitted to the protocol of renal disease induction using weekly application of gentamicin sulfate for 4 months. CG and CTG received a 1 × 108 BMMC stained with Hoechst and were euthanized for kidney examination 21 days after BMMC injection and samples were collected for histology and immunofluorescence analysis. Histological analysis demonstrated typical interstitial lesions in kidney similarly to human disease, as tubular necrosis, glomerular destruction, atrophy tubular, fibrotic areas, and collagen deposition. We conclude that histological analysis suggest a positive application of agouti's as a model for a gentamicin inducing of kidney disease, beyond the immunofluorescence analysis suggest a significant migration of BMMC to sites of renal injury in CTG.pt_BR
dc.languageen_USpt_BR
dc.publisherWileypt_BR
dc.rightsrestrictAccesspt_BR
dc.sourceMicroscopy Research and Techniquept_BR
dc.subjectCell therapypt_BR
dc.subjectHistological analysispt_BR
dc.subjectKidney damagept_BR
dc.subjectBone marrow mononuclear cellspt_BR
dc.subjectAgoutipt_BR
dc.subjectTerapia celularpt_BR
dc.subjectAnálise histológicapt_BR
dc.subjectDanos nos rinspt_BR
dc.subjectCélulas mononucleares da medula ósseapt_BR
dc.titleKidney injury and cell therapy: preclinical studypt_BR
dc.typeArtigopt_BR
Appears in Collections:DMV - Artigos publicados em periódicos

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.